TNFRSF9
Basic information
Region (hg38): 1:7915871-7943165
Previous symbols: [ "ILA" ]
Links
Phenotypes
GenCC
Source:
- immunodeficiency 109 with lymphoproliferation (Moderate), mode of inheritance: AR
- immunodeficiency 109 with lymphoproliferation (Definitive), mode of inheritance: AR
- immunodeficiency 109 with lymphoproliferation (Strong), mode of inheritance: AR
- immunodeficiency 109 with lymphoproliferation (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Immunodeficiency 109 with lymphoproliferation | AR | Allergy/Immunology/Infectious; Oncologic | Individuals have been described as having a primary immunodeficiency, with susceptibility to sinopulmonary and other infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; Individuals have been described as developing lymphoma and HLH, and awareness may allow early recognition and management; HSCT has been described | Allergy/Immunology/Infectious; Oncologic | 30872117 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (173 variants)
- Inborn_genetic_diseases (31 variants)
- TNFRSF9-related_disorder (6 variants)
- not_specified (5 variants)
- Immunodeficiency_109_with_lymphoproliferation (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF9 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001561.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 42 | 3 | 48 | ||
| missense | 1 | 70 | 5 | 1 | 77 | |
| nonsense | 2 | 1 | 1 | 4 | ||
| start loss | 0 | |||||
| frameshift | 6 | 1 | 7 | |||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 1 | 4 | ||
| Total | 10 | 4 | 75 | 47 | 4 |
Highest pathogenic variant AF is 0.000044575256
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TNFRSF9 | protein_coding | protein_coding | ENST00000377507 | 7 | 21020 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125730 | 0 | 17 | 125747 | 0.0000676 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.364 | 134 | 146 | 0.915 | 0.00000810 | 1666 |
| Missense in Polyphen | 25 | 33.399 | 0.74853 | 420 | ||
| Synonymous | -0.00761 | 56 | 55.9 | 1.00 | 0.00000346 | 476 |
| Loss of Function | 2.54 | 3 | 12.8 | 0.234 | 6.98e-7 | 149 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000210 | 0.000210 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.0000704 | 0.0000703 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000654 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for TNFSF9/4-1BBL. Possibly active during T cell activation.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);T-Cell antigen Receptor (TCR) Signaling Pathway;the 41bb-dependent immune response;TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Immune System;TNFs bind their physiological receptors;Downstream signaling in naïve CD8+ T cells
(Consensus)
Recessive Scores
- pRec
- 0.281
Intolerance Scores
- loftool
- 0.334
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.13
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.545
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- apoptotic process;negative regulation of cell population proliferation;tumor necrosis factor-mediated signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;external side of plasma membrane
- Molecular function
- signaling receptor activity